REPORT

Infliximab treatment for rheumatic disease: clinical and radiological efficacy

E W St Clair

Department of Medicine, Division of Rheumatology, Duke University Medical Center, Durham, NC, USA

Correspondence to:
Correspondence to:
Dr E W St Clair, Box 3874, Duke University Medical Center, Durham, NC 27710, USA;
stcla003{at}mc.duke.edu

Infliximab is a chimeric anti-tumour necrosis factor (TNF) monoclonal antibody with high affinity and binding specificity for human TNF. Results from several well designed, controlled clinical trials show repeated infusions of infliximab with concomitant methotrexate (MTX) treatment can reduce the signs and symptoms of rheumatoid arthritis (RA). This combination of infliximab and MTX also slows the radiological progression of joint damage, decreases functional disability, and improves qualify of life. These remarkably positive results have led to the investigation of infliximab treatment for other rheumatic diseases. Recently, controlled studies have shown treatment with infliximab can benefit patients with active spondyloarthropathy. TNF has fast become an important therapeutic target in rheumatology.

Keywords: infliximab; ankylosing spondylitis; tumour necrosis factor

Abbreviations: RA, rheumatoid arthritis; MTX, methotrexate; TNF, tumour necrosis factor ; CRP, C reactive protein

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Pavelka, K, Jarosova, K, Suchy, D, Senolt, L, Chroust, K, Dusek, L, Vencovsky, J (2009). Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Ann Rheum Dis 68: 1285-1289 [Abstract] [Full Text]  
• Amano, T., Yamasaki, S., Yagishita, N., Tsuchimochi, K., Shin, H., Kawahara, K.-i., Aratani, S., Fujita, H., Zhang, L., Ikeda, R., Fujii, R., Miura, N., Komiya, S., Nishioka, K., Maruyama, I., Fukamizu, A., Nakajima, T. (2003). Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17: 2436-2449 [Abstract] [Full Text]